Fred Schwarzer - 12 Mar 2022 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
CEO and President, Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
12 Mar 2022
Net transactions value
$0
Form type
4
Filing time
15 Mar 2022, 20:53:12 UTC
Previous filing
17 Nov 2021
Next filing
17 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Stock Option (right to buy) Award $0 +350,000 $0.000000 350,000 12 Mar 2022 Common Stock 350,000 $17.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48 of the shares subject to the option shall vest on April 12, 2022 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.